SLG
ZGNX

Stanley-Laman Group’s Zogenix, Inc. ZGNX Stock Holding History

Stanley-Laman Group’s Portfolio ZGNX Stock Details ZGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-26,320
Closed -$400K – 306
2021
Q3 		$400K Buy
+26,320
New +$411K 0.05% 230

Other funds holding ZGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Stanley-Laman Group's ZGNX Position: Q4 2021 in Review

Stanley-Laman Group sold out of Zogenix, Inc. (ZGNX) in Q4 2021, closing a stake of 26,320 shares — an estimated $400K sold.

Stanley-Laman Group first reported a position in ZGNX in Q3 2021 and held it in 1 quarter. The position peaked at $400K in Q3 2021. 156 funds tracked by Wall St. Rank hold ZGNX as of Q4 2021.

  • Stanley-Laman Group reported no remaining Zogenix, Inc. position as of Q4 2021 after selling out during the quarter.
  • Stanley-Laman Group sold 26,320 Zogenix, Inc. shares in Q4 2021, an estimated $400K.
  • Stanley-Laman Group first reported a position in Zogenix, Inc. in Q3 2021 and held it in 1 quarter.
  • Stanley-Laman Group's Zogenix, Inc. position peaked at $400K in Q3 2021.
  • 156 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q4 2021.

Based on Stanley-Laman Group's 13F filing for Q4 2021, filed 25 Jan 2022.